Category: Service Provider
Service Provider
Improving medical device safety from pre-review to post-market.
It pays to remember an old adage: "Better to be safe than sorry." Indeed, many medical device manufacturers are re-evaluating their quality systems as a result of the Food & Drug Administration's recent review of pre-market notifications and a FY 2011 budget request for additional funds to address product safety. Device makers should heed this advice and take the necessary steps to pro-actively — rather than reactively — address compliance issues.
St. Louis-based Express Scripts is set to launch a national pilot for Vitality’s GlowCap pill reminder device; Kaiser CMIO on mHealth opportunity; Aetna offers SMS, apps, mobile web services; and Epocrates CTO, CMO talk EHRs.
Express Scripts inks pilot deal for GlowCap St. Louis-based pharmacy benefit manager Express Scripts is set to launch a national pilot for Vitality's GlowCap pill reminder device. Express Scripts plans to begin a small version of the pilot in about a month's time and will launch a larger trial focused on drugs related to cholesterol, diabetes, high blood pressure and heart failure during the summer months. Express Scripts notes that while the trial's purpose is to determine the efficacy of GlowCap's reminder service, the companies are also eager to learn more about how patients take medication and why they fail to take it at times.
Biocell Center Corp. and the Caritas Christi Health Care network of hospitals launch a program to preserve stem cells from amniotic fluid.
Biocell Center Corp. and Caritas Christi Health Care inked a deal to start a cryopreservation service for amniotic fluid stem cells.
The Italian biotech firm, which has its U.S. headquarters in Medford, Mass., and New England's largest community hospital network will use Biocell's method of preserving stem cells obtained during routine second-trimester amniocentesis procedures. The mesenchymal stem cells can be stored for decades and are believed to hold the key to treating or even eventually curing a raft of diseases. Parents can opt to preserve the cells for use in the event of future illness for themselves or their children.
Congress has demonstrated that it is incapable of designing policies to reform healthcare reimbursement and it doesn't have the political courage to set standards and allow the incentives created by those standards to force change.
Three health care reimbursement developments of interest in the last few days:
Sometimes less is more when gauging the right level of technical jargon to use in clients' marketing campaigns.
Former DuPuy manufacturing engineer John Ferris will lead Millstone Medical Outsourcing's manufacturing operations.
Millstone Medical Outsourcing tapped former DePuy official John Ferris to be its new director of manufacturing engineering.
The Fall River, Mass.-based contract manufacturer said Ferris, who will lead its efforts to use new manufacturing and automation technology, has 25 years' experience including stints at Johnson & Johnson (NYSE:JNJ) orthopedics subsidiary DePuy "and other prominent companies," according to a press release.
Imaging data management provider Amicas Inc. is leaving private equity firm Thoma Bravo LLC at the altar in favor of a higher offer from Midwestern competitor Merge Healthcare Inc., despite its initial disdain and a $9 million breakup fee.
Amicas Inc. (NSDQ:AMCS) jilted its erstwhile buyer, private equity firm Thoma Bravo LLC, in favor of a higher offer from Merge Healthcare Inc. (NSDQ:MRGE) that it initially met with disdain.
